Calcidiol Deficiency in a Patient with Growth Hormone Deficiency

24/7 BOOK APPOINTMENTS

Case Study:

Patient Background:

  • Name: Thomas Reed
  • Age: 38 years
  • Gender: Male
  • Medical History: Diagnosed with adult-onset growth hormone deficiency (GHD) due to a non-functioning pituitary adenoma. Underwent transsphenoidal surgery and has been on GH replacement therapy. Struggles with fatigue, reduced muscle strength, and has a history of stress fractures.

Presenting Complaint:

Thomas visited his endocrinologist for a routine follow-up for his GHD. He reported persistent fatigue, muscle weakness, and concerns about his recent stress fractures, despite stable GH replacement therapy.

Initial Assessment:

Physical examination revealed decreased muscle mass and tone. His GH therapy dosage appeared adequate based on his IGF-1 levels. The endocrinologist considered the possibility of additional factors contributing to his symptoms, particularly focusing on his bone health.

Laboratory Tests and Imaging:

  • IGF-1 Levels: Within the target range, indicating adequate GH replacement.
  • Calcidiol (25-hydroxyvitamin D) Test: Significantly low levels.
  • Bone Densitometry: Indicated decreased bone mineral density, suggesting osteopenia.
  • Serum Calcium and Phosphate: Within normal limits.

Diagnostic Consideration:

Thomas’s significantly low calcidiol levels, coupled with decreased bone mineral density, raised concerns about vitamin D deficiency exacerbating his bone health issues and contributing to his symptoms of fatigue and muscle weakness.

Management:

Thomas was started on high-dose vitamin D supplementation to correct his calcidiol deficiency. His endocrinologist recommended dietary modifications to include foods rich in vitamin D and calcium, along with safe sun exposure practices. Weight-bearing exercises were also advised to improve his bone density and muscle strength.

Follow-up:

Over the next six months, Thomas reported a gradual improvement in his energy levels and muscle strength. He remained compliant with his vitamin D supplementation and lifestyle changes.

Interesting Finding:

A follow-up test showed significant improvement in his calcidiol levels. A repeat bone densitometry after a year showed improvement in bone density. Thomas also experienced a reduction in the frequency of stress fractures and an overall improvement in his quality of life.

Discussion:

This case underscores the importance of monitoring and managing calcidiol levels in patients with GHD. Thomas’s case illustrated how addressing calcidiol deficiency could lead to improvements in bone health, muscle strength, and overall well-being, highlighting the interconnected nature of GH replacement therapy, vitamin D metabolism, and bone health.

Conclusion:

Thomas’s case emphasizes the need for a comprehensive approach in managing GHD. Regular screening for calcidiol deficiency and appropriate management strategies are vital. This case illustrates the positive impact of addressing calcidiol deficiency on improving the quality of life in patients with endocrine disorders, advocating for a holistic approach to disease management that includes addressing micronutrient deficiencies.

Calcidiol

Related Blogs
A Hormonal Tango in the Quest.

Case Study: Growth hormone (GH) deficiency is a rare endocrine disorder characterized by the insufficient production of growth hormone by.

Read More
Comprehensive Management of PCOS with Dopamine.

Case Study:  Introduction This case study focuses on the management of Sarah, a 30-year-old woman diagnosed with Polycystic Ovary Syndrome.

Read More

Good Comment